Alkylating agents: all 3,295 studies that test it
Page 20 of 33. Open to participants first (456), then studies with results posted, then the rest; newest registration first within each.
- Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)Active, not recruitingNCT02870907Phase 2
- Conservative Treatments of RetinoblastomaActive, not recruitingNCT02866136Phase 2
- Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantActive, not recruitingNCT02861417Phase 2
- EDOCH Alternating With DHAP for New Diagnosed Younger MCLCompletedNCT02858804Phase 4
- A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLCStatus unknownNCT02852083Phase 2
- LBL-2016 for Children or Adolescents in ChinaActive, not recruitingNCT02845882Phase 3
- Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic AnemiaCompletedNCT02845596Not applicable
- Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma MultiformeStatus unknownNCT02844062Phase 1
- ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic AnemiaStatus unknownNCT02838992Phase 4
- Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine TumorsCompletedNCT02838342Phase 2
- BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's LymphomaStatus unknownNCT02836639Phase 2
- A Clinical Trial on Whole-brain Radiotherapy With Temozolomide Concurrent Chemotherapy or Avoidance of Hippocampus for Patients of Brain MetastasesStatus unknownNCT02832635Phase 2
- Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWithdrawnNCT02831179Phase 1
- Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and ChondrosarcomaCompletedNCT02821507Phase 2
- Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma TreatmentStatus unknownNCT02812654Phase 2
- PTCy and Ruxolitinib GVHD Prophylaxis in MyelofibrosisCompletedNCT02806375Phase 1/2
- GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory LeukemiaCompletedNCT02799147Phase 1/2
- Cyclophosphamide for Nasopharyngeal CarcinomaCompletedNCT02794077Phase 2
- Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and OverStatus unknownNCT02792491Phase 2
- Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian CancerActive, not recruitingNCT02785250Phase 1/2
- Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell TransplantationStatus unknownNCT02784561Phase 4
- Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell TumorStatus unknownNCT02784054Phase 2
- Response Based Treatment for Children With Unresectable Localized Soft Tissue SarcomaStatus unknownNCT02784015Phase 2
- Chemotherapy Plus Reduced Radiotherapy in Intracranial GerminomaStatus unknownNCT02782754Phase 2
- Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic LeukemiaCompletedNCT02779283Phase 1
- Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple MyelomaTerminatedNCT02773550Phase 4
- Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung CancerStatus unknownNCT02772107Phase 2/3
- Response-based Treatment of High-risk NeuroblastomaStatus unknownNCT02771743Phase 2
- A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent GlioblastomaCompletedNCT02770378Phase 1/2
- CCRT With Temozolomide Versus RT Alone in Patients With IDH Wild-type/TERT Promoter Mutation Grade II/III GliomasStatus unknownNCT02766270Early Phase 1
- NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/AdolescentsCompletedNCT02763475Phase 2
- Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase IIICompletedNCT02761070Phase 3
- CyBeR Association in Relapsed/Refractory DLBCLStatus unknownNCT02758925Phase 2
- Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus ErythematosisCompletedNCT02756546Phase 1/2
- Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer PatientsCompletedNCT02755844Phase 1/2
- Bendamustine Plus Subcutaneous Rituximab in Patients With Diffuse Large B-cell LymphomaStatus unknownNCT02753062Phase 2
- Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCLStatus unknownNCT02747732Phase 2
- Mitomycin C Trabeculectomy Trial for Glaucoma in EthiopiaWithdrawnNCT02744690Not applicable
- Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell LymphomaCompletedNCT02728531Phase 1
- Protocol for the Treatment of Metastatic Ewing SarcomaCompletedNCT02727387Phase 2
- Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For LymphomaWithdrawnNCT02724904Phase 1/2
- Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven MedulloblastomaActive, not recruitingNCT02724579Phase 2
- International Randomised Phase III Clinical Trial in Children With Acute Myeloid LeukaemiaActive, not recruitingNCT02724163Phase 3
- Phase II Trial for the Treatment of Relapsed OsteosarcomaTerminatedNCT02718482Phase 2
- Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)CompletedNCT02710734Phase 2
- Allogeneic Stem Cell Transplantation for Children With CMLCompletedNCT02707393Phase 2/3
- Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)WithdrawnNCT02702960Phase 2
- Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed LymphomaWithdrawnNCT02701673Phase 1/2
- A Study to Evaluate the Efficacy and Safety of Mabthera Alone and in Combination With Either Cyclophosphamide or Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT02693210Phase 2
- Bendamustine and Rituximab Combination Therapy for Cold Agglutinin DiseaseCompletedNCT02689986Phase 2
- Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid TumorsWithdrawnNCT02689336Phase 2
- Sequential Regimen of Bendamustin-Debulking Followed by Ofatumumab and Ibrutinib in CLL Patients (CLL2-BIO)CompletedNCT02689141Phase 2
- Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/LymphomaStatus unknownNCT02685670Phase 1/2
- Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain TumorsTerminatedNCT02684071Phase 2
- Denosumab as an add-on Neoadjuvant Treatment (GeparX)CompletedNCT02682693Phase 2
- Radiation Therapy and Combination Chemotherapy for MedulloblastomaStatus unknownNCT02681705Phase 2
- Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell DiseaseTerminatedNCT02678143Phase 1
- Phase II Study About Combination CHOP-21, Obinutuzumab and Ibrutinib in Untreated Young High Risk DLBCL Patients.TerminatedNCT02670317Phase 2
- BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCTCompletedNCT02670252Phase 3
- Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer PatientsStatus unknownNCT02670109Phase 2
- Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma MultiformeStatus unknownNCT02663440Phase 2
- HD21 for Advanced StagesActive, not recruitingNCT02661503Phase 3
- Allo HSCT Using RIC for Hematological DiseasesCompletedNCT02661035Phase 2
- Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALLStatus unknownNCT02660762Phase 2
- URMC Related Haplo-identical Donor BMTCompletedNCT02660281Phase 1
- Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain MetastasesCompletedNCT02654106Phase 2
- A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid TumorsTerminatedNCT02653196Early Phase 1
- Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus NephritisCompletedNCT02645565Phase 4
- Pterygium Head Body MMC1: Two Different Surgical Procedures and Their Effect on Endothelial Cell Count.Status unknownNCT02641132Phase 4
- Genomics-Based Target Therapy for Children With Relapsed or Refractory MalignancyStatus unknownNCT02638428Phase 2
- A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)Status unknownNCT02630368Phase 1/2
- Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic LeukemiaActive, not recruitingNCT02629809Phase 2
- High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous DiseaseActive, not recruitingNCT02629120Phase 1/2
- Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCTTerminatedNCT02627573Phase 2
- PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC TrialActive, not recruitingNCT02624973Phase 2
- Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomaWithdrawnNCT02623920Phase 2
- CD123 Redirected Autologous T Cells for AMLTerminatedNCT02623582Early Phase 1
- Clinical Trial to Evaluate Safety and Efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) With Mitomycin C Used During Surgery for Treatment of Locally Advanced Colorectal CarcinomaStatus unknownNCT02614534Phase 3
- Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast CancerCompletedNCT02613026Phase 3
- Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast CancerCompletedNCT02605915Phase 1
- Temozolomide in Preventing Brain Metastases in Small Cell Lung CancerStatus unknownNCT02605811Phase 2
- Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or GliosarcomaWithdrawnNCT02599090Phase 2
- Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade PineoblastomaCompletedNCT02596828Phase 2
- Safety and Efficacy Study of CNOP Chemotherapy in Diffuse Large B Cell LymphomaWithdrawnNCT02595242Phase 1
- Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast CancerCompletedNCT02593227Phase 2
- Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer PatientsCompletedNCT02583828Not applicable
- Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)Active, not recruitingNCT02570542Phase 2
- Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic MalignanciesCompletedNCT02566395Phase 3
- Adjuvant Chemotherapy of Three-step Regimen in Ovarian CancerStatus unknownNCT02562365Phase 2
- Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell LymphomaWithdrawnNCT02548468Phase 1
- VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT)Status unknownNCT02544425Phase 2
- Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaWithdrawnNCT02538926Phase 2
- The Research of Standard Diagnosis and Treatment for HSPN in ChildrenStatus unknownNCT02532777Phase 2
- Safety and Efficacy of an Immunoablative Nonmyeloablative Conditioning Protocol for Autologous Bone Marrow Transplantation (BMT) in Patients With Multiple Sclerosis (MS)Status unknownNCT02529839Not applicable
- Carfilzomib in Combination With Cyclophosphamide and Etoposide for ChildrenCompletedNCT02512926Phase 1
- Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed GlioblastomaTerminatedNCT02510950Phase 1
- Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid MalignanciesStatus unknownNCT02507479Phase 2
- Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade GliomasTerminatedNCT02507232Early Phase 1
- Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or SarcomaWithdrawnNCT02507076Not applicable
- Bendamustine Plus Brentuximab Vedotin in HL and CD30+ PTCL in First Salvage SettingTerminatedNCT02499627Phase 2